share-Owners of the Company (0.10 ) (0.07 ) (0.03) (40.56%) Attributable to Owners of the Company (84.18) (59.89) (24.29 ) (40.56%) Non-controlling interests - - - - 1. Operating revenue In summary
-100% Net Profit after Extra Items -344 -22 1,464% 239 -244% -105 0.2 -52,600% EPS (Baht/Share) -0.34 -0.02 1,600% 0.23 -248% -0.10 0.0002 -50,100% Note: (1) Adjusted EBITDA refers to EBITDA excluding
much and still focus on maintaining our market share in domestic market by improving our sales strategy as well as developing new products to meet customer demand and driving to expand the export market
measurements directly affect with the business of Wuttisak Clinic Intergroup Co., Ltd. (“Wuttisak Clinic” or “WCIG” indirect subsidiary, hold share by WCI Holding PCL) to close all branches resulting in lack of
requirement by the Bank of Thailand with the capital adequacy ratio as of end of March 2021 at 16.75%. For Capital market business, the market share (SET and mai excluding proprietary trading) of Kiatnakin
methods of Acquisition/Disposition Remark DV8 PUBLIC COMPANY LIMITED (DV8) Mr. THANARATH THANAVUTWATTHANA Reporter Common Share 23/05/2019 1,300,000 0.45 Purchase Link DV8 PUBLIC COMPANY LIMITED (DV8) Mr
of Food Chain which should not be affected much and still focus on maintaining our market share in domestic market by improving our sales strategy as well as developing new products to meet customer
March 31, 2020 at Baht 0.51 per share, totaling Baht 191,250,000. The schedules are as follows: 1.1 The Record Date to determine the list of shareholders who have the rights to receive the interim
(%) 12.31% 29.10% EPS (Baht/Share) 0.245 0.16 Consolidated financial statement 31 December 2019 Q1/2020 D/E RATIO (Times) 1.15 1.15 Please be informed accordingly Yours sincerely, -Signature- (Miss Nilrat